PERCEPTIVE ADVISORS LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+119,081
(14.3%)
New positions
51
Sold out positions
33
Turnover %
39.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NBIX | 35,296 | 90.3% |
| LION BIOTECHNOLOGIES | 28,320 | NEW |
| HRTX | 24,515 | NEW |
| PTCT | 17,558 | NEW |
| ACAD | 16,204 | NEW |
| VERSARTIS INC | 15,063 | NEW |
| TVTX | 14,770 | 200.5% |
| SGMO | 14,464 | NEW |
| PRTA | 13,409 | NEW |
| FLAMEL TECHNOLOGIES SA | 10,720 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| CELG | -57,248 | -66.5% |
| *AEGERION PHARMACEUTICALS INC | -31,775 | -100.0% |
| MANNKIND CORP | -19,772 | -100.0% |
| VRTX | -19,171 | -31.8% |
| ABBV | -15,040 | -81.4% |
| BIIB | -11,190 | -100.0% |
| THE CIGNA GROUP | -10,829 | -99.0% |
| HEARTWARE INTERNATIONAL INC | -7,977 | -100.0% |
| Lowes Companies Inc | -7,915 | -97.8% |
| MGNX | -7,193 | -36.5% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
60,346
(6.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|